Titan Medical Inc.  

(Public, CVE:TMD)   Watch this stock  
Find more results for Bruce A. Wolffing
2.06
-0.03 (-1.44%)
Apr 22 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.93 - 2.10
52 week 0.38 - 2.76
Open 2.09
Vol / Avg. 751,340.00/791,886.00
Mkt cap 175.59M
P/E     -
Div/yield     -
EPS -0.13
Shares 85.24M
Beta -0.45
Inst. own     -

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -138.01% -90.88%
Return on average equity -178.74% -111.09%
Employees 12 -
CDP Score - -

Address

Suite 1000, 170 University Avenue
TORONTO, ON M5H 3B3
Canada
+1-416-5487522 (Phone)

Website links

Description

Titan Medical Inc. (Titan) is a development-stage company focused on the development and commercialization of robotic surgical technologies. The Company is developing the Amadeus Robotic Surgical Platform (Amadeus), a four-armed robotic surgical system. The development of Amadeus has three phases. The Amadeus system includes single and multiple port access capability with the objective of performing complex procedures directed by the surgeon team. During the year ended December 31, 2011, the Company announced its Amadeus Composer Surgical System, (Amadeus Composer), designed to allow for the expansion of robotic surgery into areas of surgical specialties and procedures. The Amadeus Composer is designed to allow surgeons to perform procedures within small to medium size surgical spaces such as ear, nose and throat applications.

Officers and directors

John T. Hargrove Chairman of the Board, Interim Chief Executive Officer
Reiza Rayman M.D. President, Director
Age: 49
Stephen D. Randall Chief Financial Officer, Secretary
Joseph Talarico Senior Vice President - Business Development
John Valvo Vice President
Bruce Giles Wolff Director
John E. Barker Independent Director
Martin C. Bernholtz Independent Director